MYC and transcription elongation

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 1, 2014, Pages

  Rahl, Peter B ^a   Young, Richard A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAX PROTEIN; MYC PROTEIN; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; MNT PROTEIN, HUMAN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; B CELL LYMPHOMA; BINDING AFFINITY; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; DIMERIZATION; DNA BINDING; GENE CONTROL; GENE EXPRESSION; NONHUMAN; TRANSCRIPTION ELONGATION; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; ONCOGENE MYC; PHYSIOLOGY; PROMOTER REGION; REVIEW;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; TRANSCRIPTION ELONGATION, GENETIC; TRANSCRIPTION FACTORS;

EID: 84891750231     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a020990     Document Type: Article

References (115)

1. Adelman K., Marr MT, Werner J, Saunders A, Ni Z, Andrulis ED, Lis JT. 2005. Efficient release from promoter-proximal stall sites requires transcript cleavage factor TFIIS. Mol Cell 17: 103-112.
2. Amati B., Alevizopoulos K, Vlach J. 1998. Myc and the cell cycle. Front Biosci 3: d250-d268.
3. Amati B., Frank SR, Donjerkovic D, Taubert S. 2001. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta 1471: M135-M145.
4. Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, Fatyol K, Fahlen S, Hydbring P, SoderbergO, Grummt I, et al. 2005. c-Myc associates with ribosomalDNA and activates RNA polymerase I transcription. Nat Cell Biol 7: 303-310.
5. Ayer D.E., Eisenman RN. 1993. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/ macrophage differentiation. Genes Dev 7: 2110-2119.
6. Ayer D.E., Kretzner L, Eisenman RN. 1993. Mad: A heterodimeric partner forMax that antagonizesMyc transcriptional activity. Cell 72: 211-222.
7. Barboric M., Nissen RM, Kanazawa S, Jabrane-Ferrat N, Peterlin BM. 2001. NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell 8: 327-337.
8. Baudino T.A., Cleveland JL. 2001. The Max network gone mad. Mol Cell Biol 21: 691-702.
9. Bayley J.P., Devilee P. 2012. TheWarburg effect in 2012. Curr Opin Oncol 24: 62-67.
10. Bernard S., Eilers M. 2006. Control of cell proliferation and growth byMyc proteins. Results Probl Cell Differ 42: 329-342.
11. Blackwood E.M., Eisenman RN. 1991. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNAbinding complex withMyc. Science 251: 1211-1217.
12. Bouchard C., Marquardt J, Bras A, Medema RH, Eilers M. 2004. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J 23: 2830-2840.
13. Chandriani S., Frengen E, Cowling VH, Pendergrass SA, Perou C.M., Whitfield ML, Cole MD. 2009. A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response. PLoS ONE 4: e6693.
14. Chao S.H., Price DH. 2001. Flavopiridol inactivates P-TEFb and blocks mostRNApolymerase II transcription in vivo. J Biol Chem 276: 31793-31799.
15. Cheng B., Li T, Rahl PB, Adamson TE, Loudas NB, Guo J, Varzavand K., Cooper JJ, Hu X, Gnatt A, et al. 2012. Functional association of Gdown1 with RNA polymerase II poised on human genes. Mol Cell 45: 38-50.
16. Cole M.D., Cowling VH. 2008. Transcription-independent functions of MYC: Regulation of translation and DNA replication. Nat Rev Mol Cell Biol 9: 810-815.
17. Conacci-Sorrell M, McFerrin L, Eisenman RN. 2013. An overview of MYC and its interactome. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a014357.
18. Conaway R.C., Conaway JW. 2013. The Mediator complex and transcription elongation. Biochim Biophys Acta 1829: 69-75.
19. Core LJ, Waterfall JJ, Lis JT. 2008. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322: 1845-1848.
20. Cowling V.H., Cole MD. 2007. Turning the tables: Myc activates Wnt in breast cancer. Cell Cycle 6: 2625-2627.
21. Cowling V.H., Cole MD. 2010. Myc regulation of mRNA cap methylation. Genes Cancer 1: 576-579.
22. Dai M.S., Lu H. 2008. Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer. J Cell Biochem 105: 670-677.
23. Dang CV. 2010. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res 70: 859-862.
24. Dang C.V., O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. 2006. The c-Myc target gene network. Semin Cancer Biol 16: 253-264.
25. Dang C.V., Le A, Gao P. 2009. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res 15: 6479-6483.
26. Donner A.J., Ebmeier CC, Taatjes DJ, Espinosa JM. 2010. CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat Struct Mol Biol 17: 194-201.
27. Eberhardy S.R., Farnham PJ. 2001. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J Biol Chem 276: 48562-48571.
28. Eberhardy S.R., Farnham PJ. 2002. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J Biol Chem 277: 40156-40162.
29. Eilers M., Eisenman RN. 2008. Myc's broad reach. Genes Dev 22: 2755-2766.
30. Facchini L.M., Penn LZ. 1998. The molecular role of Myc in growth and transformation: Recent discoveries lead to new insights. FASEB J 12: 633-651.
31. Feng Z., Levine AJ. 2010. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol 20: 427-434.
32. Freie B.W., Eisenman RN. 2008. RatchetingMyc. Cancer Cell 14: 425-426.
33. Fuda N.J., Ardehali MB, Lis JT. 2009. Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 461: 186-192.
34. Gallant P. 2005. Myc, cell competition, and compensatory proliferation. Cancer Res 65: 6485-6487.
35. Gargano B., Amente S, Majello B, Lania L. 2007. P-TEFb is a crucial co-factor for Myc transactivation. Cell Cycle 6: 2031-2037.
36. Gilchrist D.A., Dos Santos G, Fargo DC, Xie B, Gao Y, Li L, Adelman K. 2010. Pausing ofRNA polymerase II disrupts DNA-specified nucleosome organization to enable precise gene regulation. Cell 143: 540-551.
37. Giraud M., Yoshida H, Abramson J, Rahl PB, Young RA, Mathis D., Benoist C. 2012. Aire unleashes stalled RNA polymerase to induce ectopic gene expression in thymic epithelial cells. Proc Natl Acad Sci 109: 535-540.
38. Grandori C., Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, White RJ. 2005. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7: 311-318.
39. Grewal S.S., Li L, Orian A, Eisenman RN, Edgar BA. 2005. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat Cell Biol 7: 295-302.
40. Guccione E., Martinato F, Finocchiaro G, Luzi L, Tizzoni L, Dall' Olio V, Zardo G, Nervi C, Bernard L, Amati B. 2006. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 8: 764-770.
41. Guenther M.G., Levine SS, Boyer LA, Jaenisch R, Young RA. 2007. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130: 77-88.
42. Hanahan D., Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144: 646-674.
43. Herold S., Herkert B, Eilers M. 2009. Facilitating replication under stress: An oncogenic function of MYC? Nat Rev Cancer 9: 441-444.
44. Hoffman B., Liebermann DA. 2008. Apoptotic signaling by c-MYC. Oncogene 27: 6462-6472.
45. Hu X, Malik S, Negroiu CC, Hubbard K, Velalar CN, Hampton B, Grosu D, Catalano J, Roeder RG, Gnatt A. 2006. A Mediator-responsive form of metazoan RNA polymerase II. Proc Natl Acad Sci 103: 9506-9511.
46. Hurlin P.J., Dezfouli S. 2004. Functions of myc:max in the control of cell proliferation and tumorigenesis. Int Rev Cytol 238: 183-226.
47. Hurlin PJ, Queva C, Eisenman RN. 1997. Mnt, a novelMaxinteracting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev 11: 44-58.
48. Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K. 2005. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell 19: 523-534.
49. Ji H., Wu G, Zhan X, Nolan A, Koh C, De Marzo A, Doan HM, Fan J, Cheadle C, Fallahi M, et al. 2011. Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation. PLoS ONE 6: e26057.
50. Jiang Y.W., Veschambre P, Erdjument-Bromage H, Tempst P, Conaway J.W., Conaway RC, Kornberg RD. 1998. Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways. Proc Natl Acad Sci 95: 8538-8543.
51. Jishage M, Malik S, Wagner U, Uberheide B, Ishihama Y, Hu X, Chait BT, Gnatt A, Ren B, Roeder RG. 2012. Transcriptional regulation by Pol II(G) involving mediator and competitive interactions of Gdown1 and TFIIF with Pol II. Mol Cell 45: 51-63.
52. Kanazawa S., Okamoto T, Peterlin BM. 2000. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12: 61-70.
53. Kanazawa S., Soucek L, Evan G, Okamoto T, Peterlin BM. 2003. c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis. Oncogene 22: 5707-5711.
54. Kim Y.H., Girard L, Giacomini CP, Wang P, Hernandez-Boussard T, Tibshirani R, Minna JD, Pollack JR. 2006. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene 25: 130-138.
55. Knoepfler P.S., Zhang XY, Cheng PF, Gafken PR, McMahon SB, Eisenman RN. 2006. Myc influences global chromatin structure. EMBO J 25: 2723-2734.
56. Knuesel M.T., Taatjes DJ. 2011. Mediator and post-recruitment regulation of RNA polymerase II. Transcription 2: 28-31.
57. Krueger B.J., Varzavand K, Cooper JJ, Price DH. 2010. The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK. PLoS ONE 5: e12335.
58. Kuttler F., Mai S. 2006. c-Myc, genomic instability and disease. Genome Dyn 1: 171-190.
59. Lebofsky R., Walter JC. 2007. New Myc-anisms for DNA replication and tumorigenesis? Cancer Cell 12: 102-103.
60. Lee T.I., Young RA. 2013. Transcriptional regulation and its misregulation in disease. Cell 152: 1237-1251.
61. LevensD. 2013. CellularMYCro economics: BalancingMYC function with MYC expression. Cold Spring Harb Perspect Med 5: a014233.
62. Lin C.J., Malina A, Pelletier J. 2009. c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: Implications for anticancer therapy. Cancer Res 69: 7491-7494.
63. Lin C.Y., Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee T.I., Young RA. 2012. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151: 56-67.
64. Loven J., OrlandoDA, Sigova AA, Lin CY, Rahl PB, Burge CB, Levens D.L., Lee TI, Young RA. 2012. Revisiting global gene expression analysis. Cell 151: 476-482.
65. Loven J., Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner J.E., Lee TI, Young RA. 2013. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153: 320-334.
66. Malik S., Roeder RG. 2010. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet 11: 761-772.
67. Marks H., Kalkan T, Menafra R, Denissov S, Jones K, Hofemeister H, Nichols J, Kranz A, Stewart AF, Smith A, et al. 2012. The transcriptional and epigenomic foundations of ground state pluripotency. Cell 149: 590-604.
68. McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD. 1998. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94: 363-374.
69. McMahon SB, Wood MA, Cole MD. 2000. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol 20: 556-562.
70. Meyer N., Penn LZ. 2008. Reflecting on 25 years with MYC. Nat Rev Cancer 8: 976-990.
71. Meyer N., Kim SS, Penn LZ. 2006. The Oscar-worthy role of Myc in apoptosis. Semin Cancer Biol 16: 275-287.
72. Meyer K.D., Lin SC, Bernecky C, Gao Y, Taatjes DJ. 2010. p53 activates transcription by directing structural shifts in Mediator. Nat Struct Mol Biol 17: 753-760.
73. Murphy D.J., Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui D.A., Brown-Swigart L, Johnson L, Evan GI. 2008. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14: 447-457.
74. Muse GW, Gilchrist DA, Nechaev S, Shah R, Parker JS, Grissom SF, Zeitlinger J, Adelman K. 2007. RNA polymerase is poised for activation across the genome. Nat Genet 39: 1507-1511.
75. Nechaev S., Adelman K. 2011. Pol II waiting in the starting gates: Regulating the transition from transcription initiation into productive elongation. Biochim Biophys Acta 1809: 34-45.
76. Nechaev S., Fargo DC, dos Santos G, Liu L, Gao Y, Adelman K. 2010. Global analysis of short RNAs reveals widespread promoter-proximal stalling and arrest of Pol II in Drosophila. Science 327: 335-338.
77. Neri F., Zippo A, Krepelova A, Cherubini A, Rocchigiani M, Oliviero S. 2012. Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells. Mol Cell Biol 32: 840-851.
78. Nie Z., Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green D.R., Tessarollo L, Casellas R, et al. 2012. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151: 68-79.
79. Nieminen A.I., Partanen JI, Klefstrom J. 2007. c-Myc blazing a trail of death: Coupling of the mitochondrial and death receptor apoptosis pathways by c-Myc. Cell Cycle 6: 2464-2472.
80. Nilsson J.A., Cleveland JL. 2003. Myc pathways provoking cell suicide and cancer. Oncogene 22: 9007-9021.
81. Northcott P.A., Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T., Stutz AM, Korshunov A, Reimand J, Schumacher SE, et al. 2012. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488: 49-56.
82. Orphanides G., LeRoy G, Chang CH, Luse DS, Reinberg D. 1998. FACT, a factor that facilitates transcript elongation through nucleosomes. Cell 92: 105-116.
83. Oven I., Brdickova N, Kohoutek J, Vaupotic T, Narat M, Peterlin BM. 2007. AIRE recruits P-TEFb for transcriptional elongation of target genes in medullary thymic epithelial cells. Mol Cell Biol 27: 8815-8823.
84. Park J., Kunjibettu S, McMahon SB, Cole MD. 2001. The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis. Genes Dev 15: 1619-1624.
85. Peterlin B.M., Price DH. 2006. Controlling the elongation phase of transcription with P-TEFb. Mol Cell 23: 297-305.
86. Peterson C.W., Ayer DE. 2012. An extended Myc network contributes to glucose homeostasis in cancer and diabetes. Front Biosci 17: 2206-2223.
87. Prochownik EV. 2008. c-Myc: Linking transformation and genomic instability. Curr Mol Med 8: 446-458.
88. Ptashne M., Gann A. 1997. Transcriptional activation by recruitment. Nature 386: 569-577.
89. Rahl P.B., Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp P.A., Young RA. 2010. c-Myc regulates transcriptional pause release. Cell 141: 432-445.
90. Roussel M.F., Robinson GW. 2013. Role of MYC in medulloblastoma. Cold Spring Harb Perspect Med doi: 10.1101/ cshperspect.a014308.
91. RuggeroD. 2009. The role ofMyc-induced protein synthesis in cancer. Cancer Res 69: 8839-8843.
92. Ruggero D., Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C., Pandolfi PP. 2004. The translation factor eIF-4E promotes tumor formation and cooperateswith c-Myc in lymphomagenesis. Nat Med 10: 484-486.
93. Sabò A, Amati B. 2013. Genome recognition by Myc. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect. a014191.
94. Schlosser I., Holzel M, Hoffmann R, Burtscher H, Kohlhuber F, Schuhmacher M, Chapman R, Weidle UH, Eick D. 2005. Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line. Oncogene 24: 520-524.
95. Schuhmacher M., Kohlhuber F, Holzel M, Kaiser C, Burtscher H., Jarsch M, Bornkamm GW, Laux G, Polack A, Weidle UH, et al. 2001. The transcriptional program of a human B cell line in response toMyc. Nucleic Acids Res 29: 397-406.
96. Secombe J., Pierce SB, Eisenman RN. 2004. Myc: Aweapon of mass destruction. Cell 117: 153-156.
97. Seila A.C., Calabrese JM, Levine SS, Yeo GW, Rahl PB, Flynn RA, Young RA, Sharp PA. 2008. Divergent transcription from active promoters. Science 322: 1849-1851.
98. Shchors K., Evan G. 2007. Tumor angiogenesis: Cause or consequence of cancer? Cancer Res 67: 7059-7061.
99. Sigova A.A., Mullen AC, Molinie B, Gupta S, Orlando DA, Guenther M.G., Almada AE, Lin C, Sharp PA, Giallourakis CC, et al. 2013. Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells. Proc Natl Acad Sci 110: 2876-2881.
100. Singh A.M., Dalton S. 2009. The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 5: 141-149.
101. Soufi A., Donahue G, Zaret KS. 2012. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 151: 994-1004.
102. Sutphin P.D., Giaccia AJ, Chan DA. 2007. Energy regulation: HIF MXIes it up with the C-MYC powerhouse. Dev Cell 12: 845-846.
103. Takahashi H., Parmely TJ, Sato S, Tomomori-Sato C, Banks CA, Kong SE, Szutorisz H, Swanson SK, Martin-Brown S, Washburn M.P., et al. 2011. Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 146: 92-104.
104. Vander Heiden MG, Locasale JW, Swanson KD, Sharfi H, Heffron G.J., Amador-Noguez D, Christofk HR, Wagner G, Rabinowitz JD, Asara JM, et al. 2010. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329: 1492-1499.
105. Van Riggelen J, Yetil A, FelsherDW. 2010. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 10: 301-309.
106. Vita M., Henriksson M. 2006. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 16: 318-330.
107. Wada T., Takagi T, Yamaguchi Y, Ferdous A, Imai T, Hirose S, Sugimoto S., Yano K, Hartzog GA, Winston F, et al. 1998. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev 12: 343-356.
108. Wang W., Yao X, Huang Y, Hu X, Liu R, Hou D, Chen R, Wang G. 2013. Mediator MED23 regulates basal transcription in vivo via an interaction with P-TEFb. Transcription 4: 39-51.
109. Whyte W.A., Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey M.H., Rahl PB, Lee TI, Young RA. 2013. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153: 307-319.
110. Winkler D.D., Luger K. 2011. The histone chaperone FACT: Structural insights and mechanisms for nucleosome reorganization. J Biol Chem 286: 18369-18374.
111. Wu S.Y., Lee AY, Lai HT, Zhang H, Chiang CM. 2013. Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol Cell 49: 843-847.
112. Yamaguchi Y., Takagi T, Wada T, Yano K, Furuya A, Sugimoto S, Hasegawa J, Handa H. 1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97: 41-51.
113. Yang Z., Yik JH, Chen R, He N, Jang MK, Ozato K, Zhou Q. 2005. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell 19: 535-545.
114. Zeitlinger J., Stark A, Kellis M, Hong JW, Nechaev S, Adelman K, Levine M, Young RA. 2007. RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat Genet 39: 1512-1516.
115. Zhou Q., Li T, Price DH. 2012. RNA polymerase II elongation control. Annu Rev Biochem 81: 119-143.